# A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

> **NCT07782450** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 54 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Idiopathic Inflammatory Myositis
- Systemic Sclerosis

## Interventions

- **DRUG:** PF-08154225

## Key facts

- **NCT ID:** NCT07782450
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-19
- **Primary completion:** 2031-02-22
- **Final completion:** 2031-02-22
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07782450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07782450, "A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07782450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
